A Condition Like MS Can Worsen Without New Attacks

Credibility

Interest

Share:2 min read

Key Takeaway

In a condition called NMOSD, which can look like MS but is a different disease, most lasting disability followed attacks, though a few people worsened without one.

What They Found

Researchers followed people with NMOSD, a disease that can damage the nerves in the eyes and spinal cord. They found 32 cases of disability that worsened and did not improve by the end of the study. Most worsening followed an attack, meaning a new spell of symptoms or a clear flare-up. Six cases happened without a recorded attack, affecting five people—about 2% of the patients. Overall, lasting worsening was uncommon in this group, whose members were receiving proactive treatment.

Who Should Care and Why

People with NMOSD and their caregivers may find this study especially useful because it shows why preventing attacks remains an important care goal. It also suggests they should tell their care team about lasting changes even when there has been no obvious attack. Keeping a simple note of changes in sight, strength, or walking may make those conversations easier. Healthcare providers can use this finding as a reminder to look into new difficulties rather than assume they must follow an attack. People with MS should know that NMOSD is a different disease, so these numbers do not describe what happens in MS.

Important Considerations

Only five people had worsening without an attack, so the study cannot show how often this happens in all people with NMOSD. Worsening had to last until the end of follow-up, which means the study does not describe changes that later improved. Because the group was receiving proactive treatment, the results may differ for people whose care is different.

AI-generated summary — for informational purposes only, not medical advice

Categories:

MS Progression Specific Symptoms Caregivers

Article Topics:

Devic’s diseasecohort studylongitudinal analysisobservational datarelapse history

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Multiple sclerosis (Houndmills, Basingstoke, England) often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News